PD-1 Antibody Plus Chemo Boosts Gastric Cancer Treatment
In a groundbreaking advancement for the treatment of gastric and gastroesophageal adenocarcinoma, researchers have unveiled the findings of the ROSETTE trial—an open-label, randomized phase 2...















